Read + Share
Bajrami A, Tamanti A, Peloso A, Ziccardi S, et al. Ocrelizumab reduces cortical and deep grey matter loss compared to the
S1P-receptor modulator in multiple sclerosis. J Neurol 2024 Jan 30. doi: 10.1007/s00415-023-12179.
PMID: 38289534
|
 |
|
Bajrami A, Tamanti A, Peloso A, Ziccardi S, et al. Ocrelizumab reduces cortical and deep grey matter loss compared to the
S1P-receptor modulator in multiple sclerosis. J Neurol 2024 Jan 30. doi: 10.1007/s00415-023-12179.
PMID: 38289534
|
|
|
|